« Back to Record
Eggermont, A., Suciu, S., Mackie, R., Ruka, W., Testori, A., Kruit, W. H., Punt, C., Delauney, M., Sales, F., Groenewegen, G., Ruiter, D. J., Jagiello, I., Stoitchkov, K., Keilholz, U., Lienard, D., & EORTC Melanoma Group, (2005). Post-surgery adjuvant therapy with intermediate doses of interferon alfa 2b versus observation in patients with stage IIb/III melanoma (EORTC 18952): randomised controlled trial. Lancet, 366(9492), 1189-1196. doi:10.1016/S0140-6736(05)67482-X
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/121872



